Results 151 to 160 of about 12,023 (229)

Cabergoline Induced Pathological Gambling in an Adolescent with Prolactinoma [PDF]

Ummahan Tercan, Ezgi Sarban, Melek Yıldız, Ozlem Nida Erbasi, Mine Özkan, Aslı Derya Kardelen, Şükran Poyrazoğlu, Firdevs Baş, Feyza Darendelıler   +8 more
openalex   +1 more source

Aggressive Macroprolactinoma Refractory to Multiple Lines of Localized and Systemic Therapy. [PDF]

JCEM Case Rep
Konindala N, Paluri R, Darapu H.
europepmc   +1 more source

Pituitary Adenoma Complicated by Hydrocephalus in a Patient Treated with Cabergoline

, 2015
Ruben Van den Brande, Pascale Abrams
openalex   +1 more source

Screening for valve disease in patients with hyperprolactinaemia disorders prescribed cabergoline: a service evaluation and literature review [PDF]

, 2017
David Gamble, Rachel Fairley, Roderick Harvey, Colin Farman, Nathan Cantley, Stephen J Leslie   +5 more
openalex   +1 more source

A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test. [PDF]

Einstein (Sao Paulo)
Galliano SA, Stumpf MAM, Queiroz NL, Ferreira EHR, Craveiro FL, Gruetzmacher C, Silva GOD, Cescato VAS, Vellutini EAS, Cunha-Neto MBC, Batista RL, Glezer A.   +11 more
europepmc   +1 more source

Real-life data on pasireotide in monotherapy or combined in active Cushing's disease. [PDF]

Front Endocrinol (Lausanne)
Mondin A, Ceccato F, Scaroni C, Denaro L, Manara R, Robertazzo UM, Barbot M.   +6 more
europepmc   +1 more source

Session 23. Reproductive endocrinology [PDF]

, 2017
Bertazzoli, M., Boyer, P., Braat, D.D.M., Broglio, Grabinski, Camanni, F., Cavioni, V., Cedard, L., Cortesi, L., Cortesi, L., Crosignani, P.G., Crosignani, P.G., D'Alberton, A., De Cecco, L., Fadini, R., Faglia, G., Falsetti, L., Falsetti, L., Ferrari, C., Fioretti, P., Flamigni, F., Gastaldi, A., Gherardi, F., Gianola, D., Gianola, D., Giordano, G., Guichard, A., L'Hermite, M., Lancranjanl, I., Lepore, G., Lucianetti, M., Maria, A., Mattei, A.M., Mazzocchi, N., Meunier, K., Mignot, Th.M., Miragoli, A., Montini, M., Montini, M., Pagani, G., Pagani, G., Pagani, M.D., Pagani, M.D., Pasinetti, E., Pedroncelli, A., Pedroncelli, A., Scalon, M.F., Schoemaker, J., Sileo, F., Simionato, S., Tamburrano, G., Tengattini, F., Tengattini, F., testa, G., Webster, J., Zaro, A., Zorn, J.R.   +55 more
core  

Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers and patients with parkinson's disease [PDF]

, 2004
Masahiro Nomoto
openalex   +1 more source

Long-term primary pharmacotherapy of giant prolactinomas: A comparison of different cabergoline dosages. [PDF]

J Clin Transl Endocrinol
Václav H, Manuela V, Michal K, Adéla K, Jana J, Mikuláš K, Pavel D, David N, Václav M, Martin M, Roman L, Václav H.   +11 more
europepmc   +1 more source

Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma. [PDF]

Cureus
Alkundi A, Momoh R.
europepmc   +1 more source